Pregled bibliografske jedinice broj: 1247309
Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40- year retrospective study in Croatia
Risk factors for non-melanoma skin cancer development in renal transplant recipients: a 40- year retrospective study in Croatia // Croatian Medical Journal, 63 (2022), 2; 148-155 doi:10.3325/cmj.2022.63.148 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1247309 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Risk factors for non-melanoma skin cancer
development in renal transplant recipients: a 40-
year retrospective study in Croatia
Autori
Bašić-Jukić, Nikolina ; Borlinić, Tajana ; Tešanović, Deša ; Mokos, Ivica ; Lukić, Ivan Krešimir ; Bukvić Mokos, Zrinka
Izvornik
Croatian Medical Journal (0353-9504) 63
(2022), 2;
148-155
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
kidney transplantation ; non-melanoma skin cancer
Sažetak
Aim To determine the prevalence of non-melanoma skin cancer (NMSC) and disease-specific risk factors in renal transplant recipients (RTRs). Methods This retrospective cohort study enrolled 1232 RTRs (736 men) treated in University Hospital Center Zagreb over 40 years. The effect of sex, age at transplantation, geographic residence, dialysis vintage, and the type of immunosuppressive therapy on NMSC occurrence was investigated. Results The prevalence of NMSC was 6.81%. Overall, 60.7% of patients developed basal cell carcinoma (BCC) and 30.9% of patients developed cutaneous squamous cell carcinoma (cSCC). Only 8.3% developed both tumors. The BCC:cSCC ratio was 1.76:1. The risk for NMSC was 50% higher in men. Patients older than 50 years at transplantation were at greater risk for NMSC development. Residence in an area with higher ultraviolaet radiation (UV) exposure and dialysis vintage before transplantation did not influence NMSC development. Cyclosporine and azathioprine treatment conferred a greater risk for NMSC than tacrolimus or mycophenolate mofetil treatment. Conclusion RTRs are at high risk for NMSC development. Sex, age at transplantation, and type of immunosuppressive therapy play a role in tumor development.
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Veleučilište u Bjelovaru
Profili:
Zrinka Bukvić Mokos
(autor)
Ivan Krešimir Lukić
(autor)
Tajana Borlinić
(autor)
Ivica Mokos
(autor)
Nikolina Bašić-Jukić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE